Almac offers a broad range of drug development services from research through pharmaceutical and clinical development to commercialisation of product. Headquartered in the UK and bringing over 30 years’ commercial manufacture and packaging experience, the company provides commercial packaging solutions built upon quality and flexibility.
Facilities
With an investment of over $10 million, Almac's FDA and DEA approved site at Audubon, Pennsylvania, US, has been reconfigured to provide quality led, flexible packaging solutions; supporting high volume marketed products to niche/orphan drug launches. Utilising high-speed equipment for blistering, bottling, walleting and biopharmaceutical labelling/packaging operations, the facility provides cost-effective and reliable product supply solutions to client partners.
Packaging Solutions
Almac's GMP facility offers a range of packaging solutions, from primary packaging of solid oral dosage forms to customised secondary labelling and packaging of sterile biopharmaceutical presentations.
Primary Packaging
Formats include:
• blisters (thermoform and coldform)
• bottles, jars, tubs.
Leveraging its experience, Almac offers bespoke packaging capabilities such as multi-product blistering/packaging, eye-catching pack design and online blister printing (both flexographic and digital).
Secondary Packaging
Supported by an in-house engineering team, secondary packaging formats include:
• blister cards/wallets
• cartons
• dosepacks
• complex kit assembly.
Biopharmaceutical Packaging
With significant experience in processing temperature sensitive products, Almac performs secondary labelling and packaging of a range of biopharmaceutical presentations, including:
• vials
• ampoules
• pens and cartridges.
Booth 1230, Booth 2817, INTERPHEX 2014, 18–20 March 2014, Javits Center in New York City, US.
Almac Group Ltd, +44 28 3833 2200, info@almacgroup.com, www.almacgroup.com.